-The Hindu The government must recognise the role low-cost health IT innovations could play in improving diagnostic accuracy, including many that would be useful for rural India The diagnosis of the first patient with Ebola in the U.S. was initially missed in an emergency room late night on September 25. Thomas Duncan, a Liberian national visiting Dallas, Texas, complained of flu-like symptoms and fever, but after lab work and CT scans, was...

-The Hindu Millets in one's diet can help prevent diabetes,says Dr. Vijay Viswanathan Diabetes mellitus is a metabolic disorder in which a person has high blood glucose (sugar), either because of inadequate insulin production, or because the body's cells do not respond properly to insulin, or both. Prolonged exposure to diabetes damages important organs like the eye, the kidney, the heart and nerves, as the result of damage to small blood vessels. Heredity,...

-The Times of India NEW DELHI: In a country where obesity and diabetes, on account of high intake of fatty food, is turning into an epidemic, a unique health crisis is faced by few others. Top nutritionists working at AIIMS say the fat intake among rural population continues to be significantly lower than the Recommendatory Dietary Allowance (RDA) leading to serious health issues in them. In last 20-30 years, scientists claim, the...

-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...

-The Telegraph New Delhi: A government agency has blocked its own pledge to impose price control on more medicines by withdrawing guidelines that it had used in July this year to cap prices of drugs used to treat diabetes and cardiovascular diseases. The National Pharmaceutical Pricing Authority (NPPA) has withdrawn the guidelines issued under Paragraph 19 of the Drug Price Control Order that it had used in July this year to cap...